Live Biotherapeutic to Augment Response to Immunotherapy

A novel strain of E. Coli capable of inducing TH17 T cells to improve immune response

Published: 29th October 2019
Live Biotherapeutic to Augment Response to Immunotherapy
Please note, header image is purely illustrative. Source: Elevate, unsplash license
IP Status
  • Patent application submitted